Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Annals of Emergency Medicine
|
February 24, 2020
When I Think About Walls
Athalia R Pyzer
Human Vaccines & Immunotherapeutics
|
January 28, 2015
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
Athalia R Pyzer, David E Avigan, Jacalyn Rosenblatt
Biopreservation and Biobanking
|
June 30, 2022
Insights from a Rapidly Implemented COVID-19 Biobank Using Electronic Consent and Informatics Tools
Emily F Higgs, Blake A Flood, Athalia R Pyzer, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2022
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
Sherin Juliet Rouhani, Jovian Yu, Daniel Olson, et al.
Science Advances
|
October 7, 2022
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity
Priscilla S Briquez, Sherin J Rouhani, Jovian Yu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 9, 2021
SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II
Priscilla S Briquez, Sherin J Rouhani, Jovian Yu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 30, 2017
DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma
Rebecca Karp Leaf, Dina Stroopinsky, Athalia R Pyzer, et al.
British Journal of Haematology
|
January 21, 2017
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1
Michal Bar-Natan, Dina Stroopinsky, Katarina Luptakova, et al.
British Journal of Haematology
|
March 5, 2019
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
Myrna R Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, et al.
Leukemia
|
June 28, 2018
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
Eleni Anastasiadou, Dina Stroopinsky, Stella Alimperti, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Annals of Emergency Medicine
|
February 24, 2020
When I Think About Walls
Athalia R Pyzer
Human Vaccines & Immunotherapeutics
|
January 28, 2015
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
Athalia R Pyzer, David E Avigan, Jacalyn Rosenblatt
Biopreservation and Biobanking
|
June 30, 2022
Insights from a Rapidly Implemented COVID-19 Biobank Using Electronic Consent and Informatics Tools
Emily F Higgs, Blake A Flood, Athalia R Pyzer, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2022
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
Sherin Juliet Rouhani, Jovian Yu, Daniel Olson, et al.
Science Advances
|
October 7, 2022
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity
Priscilla S Briquez, Sherin J Rouhani, Jovian Yu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 9, 2021
SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II
Priscilla S Briquez, Sherin J Rouhani, Jovian Yu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 30, 2017
DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma
Rebecca Karp Leaf, Dina Stroopinsky, Athalia R Pyzer, et al.
British Journal of Haematology
|
January 21, 2017
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1
Michal Bar-Natan, Dina Stroopinsky, Katarina Luptakova, et al.
British Journal of Haematology
|
March 5, 2019
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
Myrna R Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, et al.
Leukemia
|
June 28, 2018
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
Eleni Anastasiadou, Dina Stroopinsky, Stella Alimperti, et al.
Page
of 2